All posts by : Felistas

Results from a recent multi-center, randomized, controlled trial demonstrate that testosterone gel does not improve long-distance mobility compared to exercise alone in older women recovering from a hip fracture.

Scientists report that they have learned how certain combinations of rearranged genes can promote the progression of a rare type of kidney cancer. The study was led by investigators at the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins Bloomberg School of Public Health.

Young people in the U.K. who lived in polluted areas during their early years are more likely to report worse general health than their peers at age 17, according to new UCL research.

Throughout history, few things have inspired as much quackery as the pills, potions and promises to slow aging, boost vitality, or extend life. Yet, amid the hype and hollow claims, a few golden truths remain. As far back as 400 BC, Hippocrates, widely considered the father of modern medicine, famously said, “Walking is man’s best medicine.” More than two millennia later, science is finally catching up with that wisdom.

Despite the popularity of semaglutide drugs like Ozempic and Wegovy for weight loss, surveys suggest that most people still prefer to lose weight without using medications. For those preferring a drug-free approach to weight loss, research shows that certain nutrients and dietary strategies can naturally mimic the effects of semaglutides.

Around the world, 20% of children are not fully immunized, leading to 1.5 million child deaths each year from diseases that are preventable by vaccination. About half of those underimmunized children received at least one vaccine dose but did not complete the vaccination series, while the rest received no vaccines at all.

Patients and clinicians have welcomed the results of the ACT4 PLATO trial, which was the first clinical trial in the world to randomly assign patients with anal cancer to receive different doses of radiotherapy.

More than 60 million people are estimated to be living with dementia, resulting in over 1.5 million deaths a year and an annual cost to the global health care economy of around US $1.3 trillion (almost £1 trillion).

A new, incision-free technique developed at UVA Health to treat debilitating brain lesions called cerebral cavernous malformations, or cavernomas, has shown great promise in early testing, halting the growth of the lesions almost entirely.

Research from The University of Western Australia has advanced the development of cancer treatments that enable immune cells to fight tumors more effectively.